| Eukaryotic translation initiation factor 3 (eIF3) subunit e is essential for embryonic development and cell proliferation D Sadato, T Ono, S Gotoh‐Saito, N Kajiwara, N Nomura, M Ukaji, L Yang, ... FEBS open bio 8 (8), 1188-1201, 2018 | 20 | 2018 |
| Mitochondrial fragmentation triggers ineffective hematopoiesis in myelodysplastic syndromes Y Aoyagi, Y Hayashi, Y Harada, K Choi, N Matsunuma, D Sadato, ... Cancer Discovery 12 (1), 250-269, 2022 | 17 | 2022 |
| Prognostic impact of TP53 mutation, monosomal karyotype, and prior myeloid disorder in nonremission acute myeloid leukemia at allo-HSCT Y Najima, D Sadato, Y Harada, K Oboki, C Hirama, T Toya, N Doki, ... Bone Marrow Transplantation 56 (2), 334-346, 2021 | 14 | 2021 |
| Development of a simple and quick immunochromatography method for detection of anti-HPV-16/-18 antibodies F Endo, T Tabata, D Sadato, M Kawamura, N Ando, K Oboki, M Ukaji, ... Plos one 12 (2), e0171314, 2017 | 11 | 2017 |
| Archival bone marrow smears are useful in targeted next-generation sequencing for diagnosing myeloid neoplasms D Sadato, C Hirama, A Kaiho-Soma, A Yamaguchi, H Kogure, ... Plos one 16 (7), e0255257, 2021 | 7 | 2021 |
| Attenuated humoral response against SARS‐CoV‐2 mRNA vaccination in allogeneic stem cell transplantation recipients T Toya, Y Atsuta, T Sanada, T Honda, D Sadato, N Sekiya, H Kogure, ... Cancer Science 114 (2), 586-595, 2023 | 6 | 2023 |
| INT6/eIF3e represses E‐cadherin expression through HIF2α in lung carcinoma A549 cells S Gotoh‐Saito, D Sadato, F Shibasaki Genes to Cells 27 (12), 689-705, 2022 | 4 | 2022 |
| Potential prognostic impact of EBV RNA‐seq reads in gastric cancer: a reanalysis of The Cancer Genome Atlas cohort D Sadato, M Ogawa, C Hirama, T Hishima, SI Horiguchi, Y Harada, ... FEBS Open bio 10 (3), 455-467, 2020 | 4 | 2020 |
| Mutation profiles of diffuse large B‐cell lymphoma transformation of splenic B‐cell lymphoma/leukemia, unclassifiable on whole‐exome sequencing S Kurosawa, T Toya, D Sadato, T Hishima, C Hirama, Y Najima, ... EJHaem 2 (4), 854-860, 2021 | 3 | 2021 |
| CHD5 gene variant predicts leptomeningeal metastasis after surgical resection of brain metastases of breast cancer R Otani, D Sadato, R Yamada, H Yajima, S Kawamura, S Shimizu, ... Journal of neuro-oncology 163 (3), 657-662, 2023 | 2 | 2023 |
| Impact of gene alterations on clinical outcome in young adults with myelodysplastic syndromes T Konishi, D Sadato, T Toya, C Hirama, Y Kishida, A Nagata, Y Yamada, ... Scientific Reports 13 (1), 2641, 2023 | 2 | 2023 |
| Establishment and characterization of a new activated B-cell-like DLBCL cell line, TMD12 T Nagao, K Yoshifuji, D Sadato, Y Motomura, M Saito, K Yamamoto, ... Experimental Hematology 116, 37-49, 2022 | 2 | 2022 |
| Presence of TP53 mutation and monosomal karyotype predict the outcome of patients with acute myeloid leukemia in non-remission at allogeneic stem cell transplantation Y Najima, D Sadato, Y Harada, C Hirama, K Oboki, T Toya, N Doki, ... Blood 132, 2168, 2018 | 2 | 2018 |
| A third dose of COVID‐19 mRNA vaccine induces limited humoral response in stem cell transplant recipients who got two vaccine doses before transplant T Toya, D Sadato, T Sanada, T Honda, Y Atsuta, N Sekiya, H Shimizu, ... EJHaem 4 (1), 309, 2023 | 1 | 2023 |
| Successful cord blood transplantation for idiopathic CD4+ lymphocytopenia K Yamamoto, Y Najima, H Iizuka, Y Harada, D Sadato, A Kanai, H Matsui, ... Acta Haematologica 144 (6), 698-705, 2021 | 1 | 2021 |
| Donor‐derived gene mutations in sex chromosome loss after stem cell transplantation. H Adachi, D Sadato, T Toya, C Hirama, K Haraguchi, J Mukae, N Shingai, ... British Journal of Haematology 195 (3), 2021 | 1 | 2021 |
| Impact of genetic alterations on central nervous system progression of primary vitreoretinal lymphoma K Yoshifuji, D Sadato, T Toya, Y Motomura, C Hirama, H Takase, ... Haematologica, 2020 | 1 | 2020 |
| Successful treatment of two cases with Philadelphia-chromosome positive acute lymphoblastic leukemia who relapsed after allogeneic stem cell transplantation and the treatments … T Tachibana, M Tanaka, Y Noguchi, Y Najima, D Sadato, Y Harada, ... Hematology 29 (1), 2360843, 2024 | | 2024 |
| Azacitidine and gemtuzumab ozogamicin as post-transplant maintenance therapy for high-risk hematologic malignancies S Kaito, Y Najima, D Sadato, C Hirama, Y Kishida, A Nagata, T Konishi, ... Bone Marrow Transplantation, 1-7, 2024 | | 2024 |
| Recurrent DDX41 mutation in very late relapse after allogeneic stem cell transplantation Y Kambara, D Sadato, T Toya, A Honda, S Kato, C Hirama, K Haraguchi, ... Leukemia 38 (3), 667-670, 2024 | | 2024 |
